Company Comparison
Foundation Medicine vs BioAnalytics Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Foundation Medicine | BioAnalytics Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Boston, Massachusetts | Cambridge |
| Founded | 2010 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | $456M | $45M |
| Valuation | — | — |
What They Build
Foundation Medicine
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
BioAnalytics Pro
Cambridge-based biotech company developing advanced analytics solutions for life sciences applications.
Key Investors
Foundation Medicine
BioAnalytics Pro
No investors listed.
Sector Overlap
Both Foundation Medicine and BioAnalytics Pro operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.